Idaho Technology, Inc. has signed a licensing agreement with E. I. du Pont de Nemours and Company acting through its DuPont Qualicon Business covering reagents or methods using SYBR® Green I technology and post-PCR melting curve analysis.
This extends Idaho Technology’s ongoing program to license its broad and valuable intellectual property portfolio in cooperation with Roche Diagnostics GmbH. The agreement, effective June 18, 2010, follows a series of intellectual property licensing agreements with a number of other biotechnology companies over the last several years.
Idaho Technology’s SYBR intellectual property has been useful expanding applications in molecular biology with the use of real time PCR products.
Idaho Technology, Inc. is a privately held biotechnology company based in Salt Lake City, Utah. Founded in 1990, Idaho Technology licensed the rapid PCR technology from the University of Utah. Through funds from the United States Department of Health and Human Services and the Department of Defense, the company has created many commercial instruments and reagents for use in research and applied fields. Several of these products, including the LightCycler® Instrument, have been sublicensed to Roche Diagnostics. Researchers, medical technicians, law enforcement officers, and soldiers in the field use the company’s devices to detect or study disease-causing organisms. For further information, please visit www.idahotech.com.